Cambridge Healthtech Institute’s 16th Annual

Immunology for Biotherapeutics

Understanding and Manipulating the Immune System for Therapeutic Advantage

October 15, 2024

Many of the exciting advances in drug discovery and development today concern the immune response and its manipulation and control. Our understanding of immune involvement in therapeutic disorders and their treatment is developing rapidly. T and B lymphocyte subsets, innate lymphoid cells (ILCs), macrophages, dendritic cells, and cytokines are all involved in a complex manner. There is the potential for manipulation for therapeutic advantage, yet the danger of disastrous consequences if not well understood. At Cambridge Healthtech Institute’s 16th Annual Immunology for Biotherapeutics symposium, attendees will find out how to utilize the immune system and overcome inhibitory factors for biotherapeutic development without overlooking potential safety issues.

Coverage will include, but is not limited to:

Current understanding of immune mechanisms, such as the role of T regulatory cells and their modulation
The role of antigen presenting cells and the basis of T cell activation
Development, activation, and function of the innate immune system
Harnessing the immune system for biotherapeutic development
Immunology safety considerations for biotherapeutics
Multispecific antibodies and drug conjugates for immune modulation and clinical benefit
Immunogenicity risk evaluation using prediction data and clinical data

The deadline for priority consideration is April 5, 2024.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: